DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Valerian is an investigational drug.
There have been 8 clinical trials for Valerian. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2008.
The most common disease conditions in clinical trials are Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, and Parkinson Disease. The leading clinical trial sponsors are Pascoe Pharmazeutische Praeparate GmbH, Steiner Arzneimittel, Berlin, Germany, and Federal University of the Valleys of Jequitinhonha and Mucuri.
Recent Clinical Trials for Valerian
|Therapeutic Effect of an Herbal Medicine on Anxiety||Millet Roux||Phase 3|
|Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety||Marjan Industria e Comercio ltda||Phase 3|
|Efficacy and Safety of St. John´s Wort/Valerian Extract Versus Placebo in Children and Adolescents With ADHD||Steiner Arzneimittel, Berlin, Germany||Phase 3|